➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
AstraZeneca
Medtronic
Mallinckrodt

Last Updated: July 28, 2021

DrugPatentWatch Database Preview

Details for Patent: 8,835,460


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,835,460 protect, and when does it expire?

Patent 8,835,460 protects SUBSYS and is included in one NDA.

This patent has twenty-two patent family members in sixteen countries.

Summary for Patent: 8,835,460
Title:Sublingual fentanyl spray and methods of treating pain
Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
Inventor(s): Kottayil; S. George (Long Grove, IL), Goskonda; Venkat R. (Phoenix, AZ), Zhu; Zhongyuan (Vernon Hills, IL), Kattookaran; Linet (Mount Prospect, IL), Parikh; Neha (Chicago, IL)
Assignee: Insys Therapeutics, Inc. (Phoenix, AZ)
Application Number:13/895,124
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,835,460
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Device; Use;

Drugs Protected by US Patent 8,835,460

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Btcp Pharma SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-001 Jan 4, 2012 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y TREATMENT OF PAIN ⤷  Free Forever Trial
Btcp Pharma SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-002 Jan 4, 2012 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y TREATMENT OF PAIN ⤷  Free Forever Trial
Btcp Pharma SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-003 Jan 4, 2012 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y TREATMENT OF PAIN ⤷  Free Forever Trial
Btcp Pharma SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-004 Jan 4, 2012 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y TREATMENT OF PAIN ⤷  Free Forever Trial
Btcp Pharma SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-005 Jan 4, 2012 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y TREATMENT OF PAIN ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,835,460

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2007208229 ⤷  Free Forever Trial
Brazil PI0707235 ⤷  Free Forever Trial
Canada 2637672 ⤷  Free Forever Trial
China 101378735 ⤷  Free Forever Trial
Cyprus 1117263 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Johnson and Johnson
Medtronic
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.